ShafferTH, MoskowitzGD. Demand-controlled liquid ventilation of the lungs. J Appl Physiol1974;36(2):208–213.
5.
HirschlRB, MerzSI, MontoyaJP, ParentA, WolfsonMR, ShafferTH, BartlettRH. Development and application of a simplified liquid ventilator. Crit Care Med1995;23(1):157–163.
6.
FuhrmanBP, PaczanPR, DeFrancisisM.Perfluorocarbon-associated gas exchange. Crit Care Med1991;19(5):712–722.
7.
LeachCL, FuhrmanBP, MorinFCIII, RathMG. Perfluorocarbon associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Crit Care Med1993;21(9):1270–1278.
8.
OverbeckMC, PranikoffT, YadaoCM, HirschlRB. Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure. Crit Care Med (1996, in press).
9.
HirschlRB, TooleyR, ParentAC, JohnsonK, BartlettRH. Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. A study model in a setting of severe respiratory failure. Chest1995;108(2):500–508.
10.
HermanLJ, FuhrmanBP, KaiserR, et al. Perfluorocarbon associated gas exchange in normal and acid-injured-large sheep (abstract). Crit Care Med1995;23(1):A264.
11.
NestiFD, FuhrmanBP, SteinhornDM, PapoMC, HermanLJ, DuffyLC, et al. Perfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med1994;22(9):1445–1452.
12.
WilcoxD, GlickP, KaramanoukianH, MorinF, FuhrmanB, LeachC.Perfluorocarbon-associated gas exchange improves pulmonary mechanics, oxygenation, ventilation, and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia model. Crit Care Med1995;23(11):1858–1863.
13.
TutuncuAS, FaithfullNS, LachmannB.Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas exchange [see comments]. Crit Care Med1993;21(7):962–969.
14.
TooleyR, HirschlRB, ParentA, BartlettRH. Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis. Crit Care Med1996;24(2):268–273.
15.
GattinoniL, D'AndreaL, PelosiP, VitaleG, PesentiA, FumagalliR.Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA1993;269(16):2122–2127.
16.
HirschlRB, OverbeckMC, ParentA, HernandezR, SchwartzS, DosanjhA, et al. Liquid ventilation provides uniform distribution of perfluorocarbon in the setting of respiratory failure. Surgery1994;116(2):159–168.
17.
QuintelM, HirschlRB, RothH, LooseR, TillmannsR, van AckernK, BartlettRH. Assessment of perfluorocarbon (PFC) distribution during partial liquid ventilation (PLV) in the setting of acute respiratory failure (abstract). Am J Respir Crit Care Med1995;151(4):A446.
18.
GaugerPG, OverbeckMC, ChamberSD, HirschlRB. Perfluorocarbon partial liquid ventilation improves gas exchange while augmenting decreased functional residual capacity in an animal model of acute lung injury. Surgery Forum1995;46:669–671.
19.
LoweC, ShafferT.Pulmonary vascular resistance in the fluorocarbon-filled lung. J Appl Physiol1986;60(1):154–159.
20.
HirschlRB, ParentA, TooleyR, McCrackenM, JohnsonK, ShafferTH, et al. Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg1995;221(1):79–88.
21.
ColtonDM, HirschlRB, JohnsonKJ, TillGO, DeanSB, BartlettRH. Neutrophil infiltration is reduced during partial perfluorocarbon liquid ventilation in the setting of lung injury. Surgery Forum1994;1055:668–670.
22.
ColtonDM, HirschlRB, TillGO, JohnsonKJ, IchibaS, PlatoCC, BartlettRH. Lung vascular permeability is reduced during partial liquid ventilation (PLV) in the setting of respiratory failure (abstract). Am J Respir Crit Care Med1995;151(4):A446.
23.
SmithT, SteinhornD, MarcucciK, ThusuK, FuhrmanB, DandonaP.A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med1995;23(9):1533–1539.
24.
VirmaniR, FinkLM, GunterK, EnglishD.Effect of perfluorochemical blood substitutes on human neutrophil function. Transfusion1984;24(4):343–347.
25.
VaraniJ, HirschlRB, DameM, JohnsonK.Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Am J Respir Cell Mol Biol (1996, in press).
26.
LeachCL, GreenspanJS, RubensteinSD, et al. Partial liquid ventilation with perflubron (LiquiVent™): a pilot safety and efficacy study in premature newborns with severe RDS who have failed conventional therapy and exogenous surfactant. Presented at the American Academy of Pediatrics Meeting, Dallas TX, 1994.
27.
HirschlRB, PranikoffT, GaugerP, SchreinerRJ, DechertR, BartlettRH. Liquid ventilation in adults, children, and full-term neonates: preliminary report. Lancet1995;346:1201–1202.
28.
PranikoffT, GaugerP, HirschlRB. Partial liquid ventilation in newborn patients with congenital diaphragmatic hernia. J Ped Surg1995;31(5):613–618.
29.
HirschlRB, PranikoffP, WiseC, OverbeckMC, GaugerP, SchreinerRJ, et al. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA1995;275(5):383–389.
30.
GaugerPG, PranikoffT, SchreinerRJ, HirschlRB. Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med1996;24(1):16–22.
HirschlRB. Pulmonary function during liquid ventilation. In: Neonatal and pediatric pulmonary graphic analysis: principles and clinical applications. DonnS, editor. Mount Kisco, NY: Futura Publishing Co, (1996, in press).